Navigation Links
In Vitro Study of Adamas Pharmaceuticals' Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
Date:9/13/2009

e antiviral therapy for serious influenza infections, with the potential to address the current limitations of antiviral potency and drug resistance."

The study results showed that the triple combination was highly synergistic in vitro, and the synergy of TCAD therapy was significantly greater than the synergy of double combinations against both susceptible and resistant viruses. Importantly, the study revealed that oseltamivir and amantadine in the triple combination contributed to antiviral activity against oseltamivir-resistant and amantadine-resistant viruses, respectively, at concentrations where they had no activity as single agents, and at concentrations that are clinically relevant.

According to the study investigators, virtually all clinical isolates of seasonal influenza in 2009 have been found to be resistant to either the adamantanes or oseltamivir. They caution that the development of resistance to currently recommended therapies may undermine their utility. While currently limited in scope, the first cases of multi-drug resistant novel influenza A/H1N1 flu are also now being reported and will need to be addressed.(1)

"Drug resistant seasonal influenza and emerging cases of multi-drug resistant novel influenza A/H1N1 virus are creating an immediate need for alternative strategies to currently available antiviral therapies," said Gregory Went, Ph.D., Chief Executive Officer and Chairman of Adamas. "The impact to the healthcare system as a result of increased admissions for those with serious flu is exacerbated during a pandemic so we believe our work is very timely. "

The CDC and WHO recommend the use of antiviral drugs for treating serious cases of influenza infection(2). Antiviral drugs that are both potent and effective against drug-resistant strains also may be important for limiting transmission of the swine flu virus during the pandemic.(3)

The da
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
4. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
5. MatTeks EpiDerm In Vitro Tissues Headed for Validation in Europe
6. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
7. New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
8. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 LifeScienceIndustryResearch.com ... Research Report on Global and China Lysine Industry ... a professional and the deep research report in ... Lysine basic information including definition, classification specifications, application, ... US, Europe , ...
(Date:4/17/2015)... 17, 2015 CVS Health Corporation (NYSE: ... Friday, May 1, 2015, at 8:30 a.m. (EDT) with ... results. An audio webcast of the conference ... portion of the CVS Health website for all interested ... This webcast will be archived and available on the ...
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., ... announced today that clinical data presented at the ... its urine-based Precision Cancer Monitoring ℠ (PCM) ... monitoring of EGFR T790M mutations in ... Detection of EGFR T790M Mutation in Urinary Circulating ...
Breaking Medicine Technology:Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... 2011 Visionary Pharmaceuticals, Inc., announced today that ... a consortium of Angel Investors. The company is ... retinoic acid related orphan receptor (ROR) modulators targeting ... disorders including rheumatoid arthritis, multiple sclerosis, psoriasis and ...
... Ind., July 26, 2011 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending July 2, 2011 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities 2Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
(Date:4/18/2015)... YORK (PRWEB) April 18, 2015 Review ... are hosting a ‘Strategies for Success’ program for cataract ... Surgeons meeting in San Diego, where eye surgeon Jeffrey ... for this invitation-only event. Dr. Martin is the Managing ... Review of Ophthalmology chose Dr. Martin to lead this ...
(Date:4/18/2015)... NC (PRWEB) April 18, 2015 Patients ... risk of developing mesothelioma later in life, but the ... from mesothelioma that is unrelated to radiation. Surviving Mesothelioma ... on its website. Click here to read it ... Australia compared the cases of 45 patients who had ...
(Date:4/18/2015)... New York, NY (PRWEB) April 18, 2015 ... their Internal Security Threat Report , which they say, “exposes ... on how many new malware variants were introduced in 2014 ... it took for Zero Day threats to be identified and ... – it is abundantly clear that doing business in a ...
(Date:4/18/2015)... Montreal, Canada (PRWEB) April 18, 2015 ... of emotions on food choices when he uttered, “Tell ... what you are.” Using food to cope with stress ... research by Queendom.com indicates otherwise. Data collected ... both genders fall victim to emotional eating, but for ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... Annual Conference, WASHINGTON, Oct. 11 ... Improving Healthcare Quality through Information,and Information Technology ... awards dinner for demonstrating leadership and excellence ... exchange to,drive improvements in the quality, safety ...
... Oct. 11 Global Med Technologies(R),Inc. (OTC ... technology company, today reported that its Wyndgate,Technologies(R) ... at the AABB,Annual Meeting and Transfusion Medicine ... The AABB, founded in 1947, is ...
... say , THURSDAY, Oct. 11 (HealthDay News) -- British researchers ... doctors early warning of lung cancer. , A team at ... different types of lung cancer and 50 others who were ... system proteins that are directed at the body,s own tissues ...
... Ltd. - (SWX: ORIDN) introduces Smart Capnography(TM), ... This new launch takes place at ... Francisco, CA. Smart Capnography combines Oridion,s ... software for improved alarm management.,Microstream allows the ...
... - Potential misuse of these infant medicines, not product safety, is ... driving the voluntary withdrawal,- This withdrawal does not affect cough and cold ... ... and cold medicines for infants and,children will occur at the October 18 and 19 ...
... Oct. 11 Businesses can no longer afford ... spend more than,75 billion dollars on obesity-attributable health ... are lost to obesity-related illness each,year(2). Other costs ... and high turnover rates. Today, business leaders, ...
Cached Medicine News:Health News:Inaugural eHealth Initiative Awards Honor Leadership in Health Care Quality Through Health IT 2Health News:Inaugural eHealth Initiative Awards Honor Leadership in Health Care Quality Through Health IT 3Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 2Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 3Health News:Immune Proteins Warn of Early Lung Cancer 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 3Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 4Health News:Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines 2Health News:Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines 3Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 2Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 3Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 4
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 27G x 7/8in (.40 x 22mm), angled 10mm from end....
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)...
... (Electronystagmography) is a complete vestibular diagnostic ... eye movements collected via electrodes. Its ... to use. Saccade, tracking and Slow ... interpretation is facilitated by graphic comparison ...
Medicine Products: